Biodesix Inc (BDSX)

Biodesix Inc (BDSX) is a Diagnostics & Research company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $279M; returns 1 day -11.5%, 1 week -10.5%, 1 year +229.4%.

Biodesix Inc. is a diagnostic solutions company specializing in the development and commercialization of blood-based tests for lung diseases, primarily lung cancer and suspicious lung nodules. The company's revenue is generated through two main segments: Lung Diagnostics and Development Services.

Groups BDSX belongs to

• Healthcare
• Life Sciences
• Health Diagnostics and Imaging
• Oncology
• Biotechnology
• Precision Medicine
• AI in Healthcare
• Healthcare Technology
• Data Analytics
• Life Sciences Tools & Services

BDSX financial model: income statement, cash flow and balance sheet